Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000816693 | SCV000957211 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-10-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 151 of the TGFBR1 protein (p.Arg151Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with thoracic aortic aneurysm and dissection (PMID: 27879313). ClinVar contains an entry for this variant (Variation ID: 659659). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TGFBR1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV001171875 | SCV001334760 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000816693 | SCV001359428 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-06-01 | criteria provided, single submitter | clinical testing | This variant is located in the TGFBR1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with thoracic aortic disease (PMID: 27879313). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002478902 | SCV002788687 | uncertain significance | Loeys-Dietz syndrome 1; Multiple self-healing squamous epithelioma | 2021-08-10 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004001791 | SCV004840379 | uncertain significance | Loeys-Dietz syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | Variant of Uncertain Significance due to insufficient evidence: This missense variant is located in the cytoplasmic domain of the TGFBR1 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant nor has this variant been reported in individuals affected with cardiovascular disorders in the literature. This variant is rare in the general population and has been identified in 0/277264 chromosomes by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the pathogenicity of this variant conclusively. |